Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vijaya Diagnostic CentreBOM:543350 -0.64%87 Return-on-Tangible-Asset is 15.54% as of Jun. 2026, which is 9% above its 10-year median of 14.20. GuruFocus rates BOM:543350 with a GF Score™ of 87/100 and a GF Value™ of ₹1,262.48 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 213 Medical Diagnostics & Research companies, Vijaya Diagnostic Centre ranks better than 86.38% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Vijaya Diagnostic Centre's annualizedNet Income for the quarter that ended in Jun. 2026 was ₹2,124 Mil. Vijaya Diagnostic Centre's average total tangible assets for the quarter that ended in Jun. 2026 was ₹13,666 Mil. Therefore, Vijaya Diagnostic Centre's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2026 was 15.54%.
The historical rank and industry rank for Vijaya Diagnostic Centre's Return-on-Tangible-Asset or its related term are showing as below:
BOM:543350'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 10.91 Med: 14.2 Max: 17.68
Current: 15
During the past 8 years, Vijaya Diagnostic Centre's highest Return-on-Tangible-Asset was 17.68%. The lowest was 10.91%. And the median was 14.20%.
BOM:543350's Return-on-Tangible-Asset is ranked better than 86.38% of 213
companies
in the Medical Diagnostics & Research industry
Industry Median: -0.78
vs BOM:543350: 15.00
Vijaya Diagnostic Centre (BOM:543350) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Vijaya Diagnostic Centre Return-on-Tangible-Asset Related Terms
Vijaya Diagnostic Centre Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Vijaya Diagnostic Centre's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vijaya Diagnostic Centre Return-on-Tangible-Asset Chart
BOM:543350 vs TMO, DHR, NTRA: Return-on-Tangible-Asset Comparison
For the Diagnostics & Research subindustry, Vijaya Diagnostic Centre's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vijaya Diagnostic Centre Return-on-Tangible-Asset vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Vijaya Diagnostic Centre's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Vijaya Diagnostic Centre's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 15.54% mean?
Vijaya Diagnostic Centre (BOM:543350) has a Return-on-Tangible-Asset of 15.54% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Vijaya Diagnostic Centre and its competitors. This is near median its historical median of 14.20. Over the past decade, Vijaya Diagnostic Centre's Return-on-Tangible-Asset has ranged from 10.91 to 17.68. According to the industry distribution chart, Vijaya Diagnostic Centre ranks #29 out of 213 companies in the Medical Diagnostics & Research industry, placing it in the top 13.6%.
Is Vijaya Diagnostic Centre's Return-on-Tangible-Asset too high?
Vijaya Diagnostic Centre's current Return-on-Tangible-Asset of 15.54% is near median its 10-year median of 14.20. Over the past 10 years, this metric has ranged from a low of 10.91 to a high of 17.68. Based on the distribution chart, Vijaya Diagnostic Centre ranks #29 out of 213 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Vijaya Diagnostic Centre has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vijaya Diagnostic Centre's Return-on-Tangible-Asset compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Vijaya Diagnostic Centre ranks #29 out of 213 companies for Return-on-Tangible-Asset. This places Vijaya Diagnostic Centre in the top 14% of its industry — outperforming the majority of peers. Historically, Vijaya Diagnostic Centre's own Return-on-Tangible-Asset has ranged from 10.91 to 17.68 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Diagnostics & Research company?
A good Return-on-Tangible-Asset depends on the Medical Diagnostics & Research industry context. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Vijaya Diagnostic Centre and its competitors. Vijaya Diagnostic Centre's current Return-on-Tangible-Asset is 15.54%, which is near median its own 10-year median of 14.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vijaya Diagnostic Centre stock overvalued right now?
Based on GuruFocus' analysis, Vijaya Diagnostic Centre (BOM:543350) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,262.48, compared to a current price of ₹1,496.35 — trading 18.5% above its estimated fair value. The current Return-on-Tangible-Asset is 15.54%, which is near median its 10-year median of 14.20. Vijaya Diagnostic Centre's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Vijaya Diagnostic Centre (BOM:543350), the current Return-on-Tangible-Asset is 15.54% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vijaya Diagnostic Centre (BOM:543350) Overvalued in 2026?
Based on GuruFocus' analysis, Vijaya Diagnostic Centre stock appears to be overvalued.
The current stock price of ₹1,496.35 is trading 18.5% above its estimated GF Value™ of ₹1,262.48.
GuruFocus considers Vijaya Diagnostic Centre to be Modestly Overvalued.
Key valuation signals for BOM:543350:
Return-on-Tangible-Asset: 15.54% (near median its 10-year median of 14.20)
GF Value™: ₹1,262.48 vs. price of ₹1,496.35 (18.5% above fair value)
No single metric tells the full story. See the BOM:543350 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vijaya Diagnostic Centre Ltd operates a diagnostic chain in Southern India. The company offers a one-stop solution for pathology and radiology testing services. It provides routine tests, specialized pathology tests, basic tests, and radiology tests. The company also offers a broad spectrum of customized health and wellness packages to its customers. The company's revenue comes from many diagnostic centers, where high-volume sales drive its earnings. The Company operates within India. The company's operations fall within a single business segment, which is Diagnostic Services.
87GF Score
Get the complete analysis for BOM:543350
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543350 has been successfully added to your 
